Trump Drug Pricing: Astellas and Kyowa Kirin Sign Japan's First MFN Deals
Astellas and Kyowa Kirin are the first Japanese drugmakers to sign most-favored-nation pricing deals with Washington. A September 29 tariff deadline explains the timing, and Japanese prices sit inside the U.S. formula.